Integrative Analysis with Monte Carlo Cross-Validation Reveals miRNAs Regulating Pathways Cross-Talk in Aggressive Breast Cancer

In this work an integrated approach was used to identify functional miRNAs regulating gene pathway cross-talk in breast cancer (BC). We first integrated gene expression profiles and biological pathway information to explore the underlying associations between genes differently expressed among normal and BC samples and pathways enriched from these genes. For each pair of pathways, a score was derived from the distribution of gene expression levels by quantifying their pathway cross-talk. Random forest classification allowed the identification of pairs of pathways with high cross-talk. We assessed miRNAs regulating the identified gene pathways by a mutual information analysis. A Fisher test was applied to demonstrate their significance in the regulated pathways. Our results suggest interesting networks of pathways that could be key regulatory of target genes in BC, including stem cell pluripotency, coagulation, and hypoxia pathways and miRNAs that control these networks could be potential biomarkers for diagnostic, prognostic, and therapeutic development in BC. This work shows that standard methods of predicting normal and tumor classes such as differentially expressed miRNAs or transcription factors could lose intrinsic features; instead our approach revealed the responsible molecules of the disease.

[1]  L. Varani,et al.  Interleukin-1 beta induces the expression and production of stem cell factor by epithelial cells: crucial involvement of the PI-3K/mTOR pathway and HIF-1 transcription complex , 2014, Cellular and Molecular Immunology.

[2]  F. Feng,et al.  Development and Validation of a Novel Platform-Independent Metastasis Signature in Human Breast Cancer , 2015, PloS one.

[3]  Carlos Caldas,et al.  BRCA1‐like signature in triple negative breast cancer: Molecular and clinical characterization reveals subgroups with therapeutic potential , 2015, Molecular oncology.

[4]  Sha Cao,et al.  Cancer may be a pathway to cell survival under persistent hypoxia and elevated ROS: A model for solid‐cancer initiation and early development , 2015, International journal of cancer.

[5]  Shuiping Gao,et al.  Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling , 2015, Oncotarget.

[6]  Guangyu Liu,et al.  Basal and therapy-driven hypoxia-inducible factor-1α confers resistance to endocrine therapy in estrogen receptor-positive breast cancer , 2015, Oncotarget.

[7]  R. Roberts,et al.  Heightened potency of human pluripotent stem cell lines created by transient BMP4 exposure , 2015, Proceedings of the National Academy of Sciences.

[8]  Fengfeng Wang,et al.  Gene Network Exploration of Crosstalk between Apoptosis and Autophagy in Chronic Myelogenous Leukemia , 2015, BioMed research international.

[9]  H. Wildiers,et al.  Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management , 2015, Breast Cancer Research.

[10]  L. Du,et al.  Serum microRNA expression signatures identified from genome‐wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer , 2015, International journal of cancer.

[11]  P. Tan,et al.  Cancer stem cell and epithelial–mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast , 2015, Breast Cancer Research and Treatment.

[12]  Lihua Wang,et al.  Detecting Key Genes Regulated by miRNAs in Dysfunctional Crosstalk Pathway of Myasthenia Gravis , 2015, BioMed research international.

[13]  M. Polenaković,et al.  Proteomics analysis of urine reveals acute phase response proteins as candidate diagnostic biomarkers for prostate cancer , 2015, Proteome Science.

[14]  Lu‐Hai Wang,et al.  Regulation of cancer metastasis by microRNAs , 2015, Journal of Biomedical Science.

[15]  Myles Brown,et al.  Loss of estrogen-regulated microRNA expression increases HER2 signaling and is prognostic of poor outcome in luminal breast cancer. , 2015, Cancer research.

[16]  S. Xie,et al.  Reduced expression levels of let-7c in human breast cancer patients , 2015, Oncology letters.

[17]  Hyunju Lee,et al.  A Computational Approach to Identifying Gene-microRNA Modules in Cancer , 2015, PLoS Comput. Biol..

[18]  R. Eils,et al.  BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence , 2014, Nature Genetics.

[19]  S. Thibodeau,et al.  Prostate cancer risk locus at 8q24 as a regulatory hub by physical interactions with multiple genomic loci across the genome. , 2015, Human molecular genetics.

[20]  P. Tassone,et al.  A p53‐Dependent Tumor Suppressor Network Is Induced by Selective miR‐125a‐5p Inhibition in Multiple Myeloma Cells , 2014, Journal of cellular physiology.

[21]  Y. Xiong,et al.  NOTCH-induced aldehyde dehydrogenase 1A1 deacetylation promotes breast cancer stem cells. , 2014, The Journal of clinical investigation.

[22]  T. McKay,et al.  Cell signalling pathways underlying induced pluripotent stem cell reprogramming. , 2014, World journal of stem cells.

[23]  T. Koru-Sengul,et al.  A Novel MAPK–microRNA Signature Is Predictive of Hormone-Therapy Resistance and Poor Outcome in ER-Positive Breast Cancer , 2014, Clinical Cancer Research.

[24]  C. Lange,et al.  Abstract 2107: Aurora A kinase and progesterone receptor cross talk in breast cancer , 2014 .

[25]  Jian-jun Zhao,et al.  Crosstalk between microRNA30a/b/c/d/e-5p and the canonical Wnt pathway: implications for multiple myeloma therapy. , 2014, Cancer research.

[26]  Crispin J. Miller,et al.  Epithelial and Stromal MicroRNA Signatures of Columnar Cell Hyperplasia Linking Let-7c to Precancerous and Cancerous Breast Cancer Cell Proliferation , 2014, PloS one.

[27]  U. Lehmann,et al.  DNA methylation, microRNAs, and their crosstalk as potential biomarkers in hepatocellular carcinoma. , 2014, World journal of gastroenterology.

[28]  Giancarlo Mauri,et al.  Integration of mRNA Expression Profile, Copy Number Alterations, and microRNA Expression Levels in Breast Cancer to Improve Grade Definition , 2014, PloS one.

[29]  S. Ambs,et al.  Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression , 2014, Proceedings of the National Academy of Sciences.

[30]  Xaralabos Varelas,et al.  The Transcriptional Regulators TAZ and YAP Direct Transforming Growth Factor β-induced Tumorigenic Phenotypes in Breast Cancer Cells*♦ , 2014, The Journal of Biological Chemistry.

[31]  B. LaFleur,et al.  Polyamines are oncometabolites that regulate the LIN28/let‐7 pathway in colorectal cancer cells , 2014, Molecular carcinogenesis.

[32]  Adam G. Diehl,et al.  Molecular and Cellular Pathobiology The Notch Pathway Inhibits TGF b Signaling in Breast Cancer through HEYL-Mediated Crosstalk , 2014 .

[33]  M. Knowles,et al.  Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity , 2014, Nature Reviews Cancer.

[34]  Isabella Castiglioni,et al.  Pathway-based expression profile for breast cancer diagnoses , 2014, 2014 36th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[35]  Giancarlo Mauri,et al.  Combined analysis of chromosomal instabilities and gene expression for colon cancer progression inference , 2014, Journal of Clinical Bioinformatics.

[36]  Antonio Colaprico,et al.  An Approach to Identify miRNA Associated with Cancer Altered Pathways , 2013, ICIAP Workshops.

[37]  S. Pastoreková,et al.  Cross-talk between HIF and p53 as mediators of molecular responses to physiological and genotoxic stresses , 2013, Molecular Cancer.

[38]  S. Drăghici,et al.  Analysis and correction of crosstalk effects in pathway analysis , 2013, Genome research.

[39]  G. Wang,et al.  Mediator MED15 modulates transforming growth factor beta (TGFβ)/Smad signaling and breast cancer cell metastasis. , 2013, Journal of molecular cell biology.

[40]  E. Sonnhammer,et al.  Statistical Assessment of Crosstalk Enrichment between Gene Groups in Biological Networks , 2013, PloS one.

[41]  W. Xie,et al.  miR-181a and inflammation: miRNA homeostasis response to inflammatory stimuli in vivo. , 2013, Biochemical and biophysical research communications.

[42]  René Bernards,et al.  A Missing Link in Genotype-Directed Cancer Therapy , 2012, Cell.

[43]  Zuhong Lu,et al.  Analysis of serum genome-wide microRNAs for breast cancer detection. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[44]  L. Hunyady,et al.  Crosstalk between TGF-β signaling and the microRNA machinery. , 2012, Trends in pharmacological sciences.

[45]  Diogo M. Camacho,et al.  Wisdom of crowds for robust gene network inference , 2012, Nature Methods.

[46]  M. Hashemi,et al.  Genetic pathways linking hemostasis and cancer. , 2012, Thrombosis research.

[47]  W. Ruf,et al.  Tissue factor proangiogenic signaling in cancer progression. , 2012, Thrombosis research.

[48]  B. Mehrara,et al.  HIF‐1α: coordinates lymphangiogenesis during wound healing and in response to inflammation , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[49]  P. Reitsma,et al.  The relationship between tissue factor and cancer progression: insights from bench and bedside. , 2012, Blood.

[50]  M. Neubauer,et al.  Thrombotic microangiopathy and disseminated intravascular coagulation associated with carcinocythemia in a patient with breast cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  Chao Cheng,et al.  Average Rank-Based Score to Measure Deregulation of Molecular Pathway Gene Sets , 2011, PloS one.

[52]  Stefano Volinia,et al.  miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia. , 2011, Blood.

[53]  Qi Zhou,et al.  Prognostic Significance of miR-181b and miR-21 in Gastric Cancer Patients Treated with S-1/Oxaliplatin or Doxifluridine/Oxaliplatin , 2011, PloS one.

[54]  W. Ruf,et al.  Tissue factor and cell signalling in cancer progression and thrombosis , 2011, Journal of thrombosis and haemostasis : JTH.

[55]  Gabriele Sales,et al.  parmigene - a parallel R package for mutual information estimation and gene network reconstruction , 2011, Bioinform..

[56]  C. Sotiriou,et al.  Global MicroRNA Expression Profiling Identifies MiR-210 Associated with Tumor Proliferation, Invasion and Poor Clinical Outcome in Breast Cancer , 2011, PloS one.

[57]  P. Marcato,et al.  Aldehyde dehydrogenase: Its role as a cancer stem cell marker comes down to the specific isoform , 2011, Cell cycle.

[58]  Anthony Fyles,et al.  MicroRNA-301 mediates proliferation and invasion in human breast cancer. , 2011, Cancer research.

[59]  Peter Carmeliet,et al.  Hypoxia and inflammation. , 2011, The New England journal of medicine.

[60]  D. Yee,et al.  MicroRNAs Link Estrogen Receptor Alpha Status and Dicer Levels in Breast Cancer , 2010, Hormones & cancer.

[61]  Riet De Smet,et al.  Advantages and limitations of current network inference methods , 2010, Nature Reviews Microbiology.

[62]  Zhiwei Wang,et al.  Cross-talk between miRNA and Notch signaling pathways in tumor development and progression. , 2010, Cancer Letters.

[63]  F. Ferrari,et al.  A MicroRNA Targeting Dicer for Metastasis Control , 2010, Cell.

[64]  Mariano J. Alvarez,et al.  A human B-cell interactome identifies MYB and FOXM1 as master regulators of proliferation in germinal centers , 2010, Molecular systems biology.

[65]  Xi Chen,et al.  The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma. , 2010, European journal of cancer.

[66]  Hua Su,et al.  MicroRNA-9 coordinates proliferation and migration of human embryonic stem cell-derived neural progenitors. , 2010, Cell stem cell.

[67]  S. Johnston,et al.  New Strategies in Estrogen Receptor–Positive Breast Cancer , 2010, Clinical Cancer Research.

[68]  Mark D. Robinson,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[69]  K. Kashiwagi,et al.  Modulation of cellular function by polyamines. , 2010, The international journal of biochemistry & cell biology.

[70]  E. Dougherty,et al.  Accurate and Reliable Cancer Classification Based on Probabilistic Inference of Pathway Activity , 2009, PloS one.

[71]  A. Falanga,et al.  Venous thromboembolism in the hematologic malignancies. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[72]  Doheon Lee,et al.  Inferring Pathway Activity toward Precise Disease Classification , 2008, PLoS Comput. Biol..

[73]  R. Johnson,et al.  Hypoxia: A key regulator of angiogenesis in cancer , 2007, Cancer and Metastasis Reviews.

[74]  J. Rak,et al.  The role of tumor-and host-related tissue factor pools in oncogene-driven tumor progression. , 2007, Thrombosis research.

[75]  Andy Liaw,et al.  Classification and Regression by randomForest , 2007 .

[76]  Emmanuel Barillot,et al.  Classification of microarray data using gene networks , 2007, BMC Bioinformatics.

[77]  Joshy George,et al.  Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. , 2006, Cancer research.

[78]  C. Nguyen,et al.  Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q , 2006, British Journal of Cancer.

[79]  M. J. van de Vijver,et al.  Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. , 2006, Journal of the National Cancer Institute.

[80]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[81]  Jun Lu,et al.  Pathway level analysis of gene expression using singular value decomposition , 2005, BMC Bioinformatics.

[82]  S. Shirasawa,et al.  Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. , 2005, Blood.

[83]  Qing Wang,et al.  Towards precise classification of cancers based on robust gene functional expression profiles , 2005, BMC Bioinformatics.

[84]  A. Kraskov,et al.  Estimating mutual information. , 2003, Physical review. E, Statistical, nonlinear, and soft matter physics.

[85]  R. Jaenisch,et al.  HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation , 2003, Cell.

[86]  A. Ohta,et al.  Differential Regulation of Two Alternatively Spliced Isoforms of Hypoxia-inducible Factor-1α in Activated T Lymphocytes* , 2001, The Journal of Biological Chemistry.

[87]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[88]  T. Barbui,et al.  The Effect of Very-low-dose Warfarin on Markers of Hypercoagulation in Metastatic Breast Cancer: Results from a Randomized Trial , 1998, Thrombosis and Haemostasis.

[89]  Holger Karas,et al.  TRANSFAC: a database on transcription factors and their DNA binding sites , 1996, Nucleic Acids Res..

[90]  Chenqi Zhao,et al.  Hormonal and Feedback Regulation of Putrescine and Spermidine Transport in Human Breast Cancer Cells (*) , 1995, The Journal of Biological Chemistry.

[91]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[92]  T S Edgington,et al.  Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.